People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rallybio Holdings, LLC | — | Other Health Care | Series D+ | $157.8M | $69.6M | 2024 |
| Hyperion Therapeutics Inc | — | Pharmaceuticals | Series B | $67.9M | $271.7M | 2014 |
Christine A. Nash at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christine A. Nash on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Hopfner | 2 | 3 |
| Kush Parmar | 1 | 10 |
| Ketan Patel | 1 | 10 |
| Tim Shannon | 1 | 9 |
| James Healy | 1 | 8 |
| James I. Healy | 1 | 7 |
| Rob Hopfner | 1 | 6 |
| Daniel Perez | 1 | 5 |
| Bijan Salehizadeh | 1 | 5 |
| Jake Nunn | 1 | 5 |
| Ronald M. Hunt | 1 | 4 |
| Jake R. Nunn | 1 | 4 |
| Lota S Zoth | 1 | 4 |
| Donald Santel | 1 | 4 |
| Ron Hunt | 1 | 4 |
| DAVID GRYSKA | 1 | 3 |
| Gaurav Aggarwal | 1 | 3 |
| KUSH M. PARMAR | 1 | 3 |
| Tim W. Shannon | 1 | 2 |
| Daniel G. Welch | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.